Dr. Bryan Wicks


Bryan Wicks, Ph.D.
Associate Director
Boehringer Ingelheim Pharmaceuticals Inc.  

Dr. Bryan Wicks is an Associate Director of Launch Analytics in the Third Party Management (3PM)/ Launch and Transfer Group at Boehringer Ingelheim Pharmaceuticals Inc.

Bryan has over 20 years of experience in Analytical Chemistry in the pharmaceutical industry and has held numerous positions at increasing levels of responsibility.

His technical areas of expertise include Raman, FTIR, and NMR spectroscopies, mass spectrometry, Gas Chromatography and HPLC.

His experience in the application of these techniques ranges from early stage drug development through product launch and lifecycle. Bryan has extensive working knowledge of method development, validation and transfer, and has authored numerous regulatory submission documents. In his previous role at Boehringer Ingelheim Roxane Inc., he led the development and application of ASAP to address challenges related to long term stability prediction of generic products.

Dr. Wicks received his B.S. degree in Chemistry and his Ph.D. in Physical Chemistry from The University of Toledo.